baber/WOPTO huggingface dataset:
Patent CA-2646829-C (CA)
Inventor: PERRIN DOMINIQUE
IPC: B65G15/54
Filed: 2007-03-30
Granted: 2014-12-30
Abstract: A spiral-link belt for use as, for example, a conveyor belt comprising a belt body formed of a series of cross-machine direction (CD) spiral coils (201, 202) linked by pintles (203) in the CD to form an endless loop and a plurality of CD drive bars. Each CD drive bar is formed of linked spiral coils (204, 206) integrated into the belt body.
Patent CA-2647885-C (CA)
Title: Compartiment a bagages, notamment compartiment clos pour cabine d'aeronef
Inventor: BOCK THOMAS-MATHIAS
IPC: B64D11/00
Filed: 2007-03-30
Granted: 2014-02-11
Abstract: Ce compartiment à bagages (2) est un compartiment clos disposé dans un espace destiné à recevoir des voyageurs dans un véhicule. Il comporte au moins une paroi (8) le délimitant et visible depuis l'espace voyageurs à l'intérieur duquel il se trouve. Ladite paroi (8) comporte au moins une ouverture (20) obturée par un matériau transparent (22).
Patent CA-2648996-C (CA)
Inventor: BLOSS MICHAEL
IPC: G07D7/12
Filed: 2007-04-11
Granted: 2018-03-06
Abstract: An apparatus for optical analysis of value documents (BN) possesses a recording area (14) in which a value document (BN) is located during analysis, and a spectrographic device (16). The latter has a spatially dispersing optical device (29) for at least partly decomposing optical radiation coming from the recording area (14) into spectrally separate spectral components propagating in different directions according to the wavelength, a detection device (30) locally resolving in at least one spatial direction for detecting the spectral components, and a collimating and focusing optic (28) for collimating the optical radiation directed from the recording area (14) onto the dispersing device (29) and for focusing at least some of the spectral components formed by means of the dispersing optical device (29) onto the detection device (30).
Patent CA-2654780-C (CA)
Title: Stretchable outer cover for an absorbent article and process for making the same
Inventor: AUTRAN JEAN-PHILIPPE MARIE
IPC: A61F13/15
Filed: 2007-06-07
Granted: 2012-08-07
Abstract: A stretchable outer cover for use with an absorbent article including an elastomeric film. The elastomeric film includes at least one skin layer that is less tacky than at least one core layer. The outer cover can include a nonwoven layer different structural combinations of spunbond fibers, meltblown fibers, and/or nanofibers. The combination of plastic and elastic components results in an outer cover that has favorable mechanical, physical, and aesthetic properties. The outer cover can be rendered either uniaxially or biaxially stretchable via a mechanical activation process.
Patent CA-2657410-C (CA)
Title: Non-precipitating alkali/alkaline earth metal and aluminum compositions made with organic hydroxyacids
Inventor: WHITE ALAN WAYNE
IPC: B01J31/14
Filed: 2007-07-13
Granted: 2012-02-07
Abstract: A stable catalyst solution suitable for catalyzing the polycondensation of reactants to make polyester polymers comprising: (i) M, wherein M is represented by an alkaline earth metal or alkali metal and (ii) aluminum and (iii) ethylene glycol and (iii) organic hydroxyacid compounds having at least three carbon atoms and less than three carboxylic acid groups when the hydroxyacid compound has 8 or less carbon atoms, wherein the molar ratio of ethylene glycol:aluminum is at least 35:1. The hydroxyacid compounds enhance to solubility of M and Al in ethylene glycol, even at even at molar ratios of M:AI approaching 1:1. There is also provided a method for the manufacture of the composition, its feed to and use in the manufacture of a polyester polymer, and, polyester polymers obtained by combining certain ingredients or containing the residues of these ingredients in the composition.
Patent CA-2658506-C (CA)
Inventor: PAULS HEINZ W
IPC: C07D498/04
Filed: 2007-07-19
Granted: 2016-01-26
Abstract: In part, the present invention is directed towards compounds with FAB I inhibiting properties. Such compounds may also inhibit other enzymes, including those similar to FAB I either structurally or functionally, for example FAB K. Said compounds and compositions thereof may be used to treat bacterial infections. Said compounds may also be used to disinfect an inanimate surface by contacting the antibacterial compound to the inanimate surface. Kits comprising said compositions that include the disclosed compounds are also provided, along with instructions for use thereof.
Patent CA-2661130-C (CA)
Title: Fold flat seat assembly with drive link
Inventor: HOMIER ROBERT I
IPC: B60N2/68
Filed: 2007-10-05
Granted: 2014-12-02
Abstract: A seat assembly is provided for supporting an occupant above a floor in an automotive vehicle. The seat assembly includes a seat cushion that is adapted to be pivotally coupled to the floor for movement between a raised position spaced above the floor and a lowered position adjacent the floor. The seat assembly also includes a seat back that is adapted to be pivotally coupled to the floor for movement between an upright position and a folded position overlying the seat cushion. At least one drive link extends between a first end pivotally coupled to the seat back and a second end pivotally and slidably coupled to the seat cushion for automatically moving the seat cushion between the raised and lowered positions in response to pivoting the seat back between the upright and folded positions thereby defining a seating position and a stowed position of the seat assembly.
Patent CA-2661865-C (CA)
Title: A cooking aid composition obtained through thermal processing
Inventor: LABRUNIE THIERRY
IPC: A23L27/21
Filed: 2007-08-23
Granted: 2014-12-02
Abstract: The invention concerns a cooking aid composition comprising Maillard reaction products together with taste enhancement property compounds without added MSG and Ribonucleotides, wherein the taste enhancement property compounds are organic acids and/or amino acids taken from the group consisting of acetic acid, citric acid, fumaric acid, malic acid, tartaric acid, succinic acid, ascorbic acid, aspartic acid, fumaric acid and the salts thereof alone or in combination.
Patent CA-2667537-C (CA)
Inventor: ASAMI TAIJI
IPC: C07K14/47
Filed: 2007-10-24
Granted: 2017-01-17
Abstract: The present invention provides stable metastin derivatives having excellent biological activities (a cancer metastasis suppressing activity, a cancer growth suppressing activity, a gonadotropic hormone secretion stimulating activity, sex hormone secretion stimulating activity, etc.). By substituting the constituent amino acids of metastin with specific amino acids, the metastin derivatives of the present invention achieve more improved blood stability, solubility, etc., reduced gelation tendency, improved pharmacokinetics, as well as exhibit an excellent cancer metastasis suppressing activity or a cancer growth suppressing activity. The metastin derivatives of the present invention also have a gonadotropic hormone secretion suppressing activity, sex hormone secretion suppressing activity, etc.
Patent CA-2680200-C (CA)
Inventor: HARTFIELD ROY J JR
IPC: F02B55/08
Filed: 2008-03-05
Granted: 2014-03-04
Abstract: The present invention is an engine, which includes a positive displacement compression process, a variably fueled, continuous combustor and/or heat exchanger, and a positive displacement, work-producing expander. This arrangement avoids the traditional stochiometric mixture requirements utilized in spark-ignition based engines and the emission problems associated with diesel engines.
Patent CA-2680209-C (CA)
Title: Systems and methods for nasal irrigation
Inventor: HOKE MARTIN R
IPC: A61H35/04
Filed: 2008-03-06
Granted: 2014-06-17
Abstract: Systems and methods for nasal irrigation are provided in which a nasal irrigation device includes a source of saline solution, an effluent receptacle, a nasal interface, a vacuum source, a fluid passageway to communicate the source of saline solution with the effluent receptacle through the nasal interface and a nasal cavity of the user, and a switch and valve assembly for selectively controlling the vacuum source and flow of the saline solution through the fluid passageway. The saline solution source bottle is disposed relative to the device to provide gravitational inducement of saline solution to the nasal interface in engagement to the device user's nostrils. A combination of the gravitational inducement and relative vacuum from an effluent receptacle generates a fluid flow for irrigating, cleansing and massaging the nasal cavity and ostia of a user.
Patent CA-2681661-C (CA)
Inventor: CORUZZI GLORIA
IPC: A23L19/00
Filed: 2008-03-24
Granted: 2015-11-24
Abstract: Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding CCAl, GLKl or bZIPl, operably linked to a plant-specific promote, wherein the CCAl, GLKl or bZIPl is ectopically overexpressed in the transgenic plants, and wherein the promoter is optionally a constitutive or inducible promoter. In other embodiments, transgenic plants in which express a lower level of CCA 1, GLKl or bZIPl are provided. Also provided herein are commercial products {e.g., pulp, paper, paper products, or lumber) derived from the transgenic plants (e.g., transgenic trees) produced using the methods provided herein.
Patent CA-2682595-C (CA)
Title: Process for preventing or remediating trithiazine deposition in high h2s wells
Inventor: HORTON ROBERT L
IPC: B01D53/34
Filed: 2008-04-01
Granted: 2012-08-07
Abstract: A method for treating a wellbore in a hydrogen sulfide-containing formation that includes injecting a first slug in the wellbore, the first slug comprising: at least one of primary amine and ammonia; and a base fluid; injecting a second slug in the wellbore, the second slug comprising: a triazine scavenger; and a base fluid; and allowing the triazine scavenger to react with the hydrogen sulfide is disclosed.
Patent CA-2683584-C (CA)
Title: Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists
Inventor: DEVITA ROBERT J
IPC: A61K31/422
Filed: 2008-04-07
Granted: 2015-07-07
Abstract: The present invention is directed to certain hydroxymethyl ether hydroisoindoline compounds of formula I which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, LUTS, depression, and anxiety. (see formula I)
Patent CA-2685290-C (CA)
Inventor: SINGH VIVEK
IPC: E21B44/00
Filed: 2008-05-21
Granted: 2013-12-31
Abstract: The invention relates to a method for performing a drilling operation at a wellsite having a drilling rig configured to advance a drilling tool into a subsurface.  The method steps include obtaining a well trajectory associated with a first volume, obtaining information related to a first subsurface entity associated with a second volume, using a three-dimensional relational comparison to determine that the first volume intersects the second volume to define a first intersection information, updating the well trajectory, based on the first intersection information, to obtain an updated well trajectory, and advancing the drilling tool into the subsurface based on the updated well trajectory.
Patent CA-2686501-C (CA)
Title: Method and device for characterising biological tissue
Inventor: CEROVIC ZORAN
IPC: G01J3/427
Filed: 2008-05-07
Granted: 2015-11-10
Abstract: The invention relates to a method and a device for conjunctively determining the content of a first chromophorous and fluorescent compound and a second chromophorous compound in a biological tissue (30). The determination of the chromophorous and fluorescent compound (33) content is carried out by optically measuring the differential absorption of said chromophorous and fluorescent compound (33) and the determination of the of the content of the second chromophorous compound (34) is carried out by optically measuring the fluorescence of the chromophorous and fluorescent compound (33). The invention uses optical adequately selected radiation (11-14) in combination with at least one filtration operation of said radiation adapted so as to use unique detection and measuring means (21) for both determinations.
Patent CA-2688167-C (CA)
Inventor: ERIKSSON ELOF
IPC: A61M1/00
Filed: 2008-05-27
Granted: 2017-05-16
Abstract: The present invention provides a device for wound treatment, comprising a chamber that includes an inner surface and defines a treatment space, the chamber being made of a flexible, impermeable material. The device further includes a plurality of structures configured to exert mechanical stress on a wound, the plurality of structures intruding from the inner surface of the chamber into the treatment space. The device further includes a tube having a first end connected to the chamber, the tube being in fluid communication with the treatment space so as to enable at least one selected from the group of applying negative pressure to the treatment space and applying a therapeutic modality.
Patent CA-2688603-C (CA)
Inventor: HUEBLER UWE
IPC: G07B17/00
Filed: 2009-12-14
Granted: 2015-11-03
Abstract: A device and a method for mail piece acceptance; with a mail item feed for mail pieces; with a user interface and with a accounting unit; with a card reader with cover plate into whose slit a postage credit card or an authorization card can be inserted; wherein after the settling the postage fee by the accounting unit a storage in secured storage containers in the storage region ensues; wherein the mail item feed is equipped with an adjustable opening of a feed shaft for depositing and for drawing in a mail piece; wherein the mail piece is an element of a set of mail pieces whose dimensions can be different; and the mail piece acceptance device has a number of devices for scanning the mail piece surface, for automatic position alignment of the mail piece, for transport, for printing a marking on the mail piece and for storage of the mail piece; wherein for storage a deflection of each of the mail pieces to a specific storage container ensues, which storage container is dimensioned corresponding to a size-accurate collection of mail pieces. The variable size of the adjustable opening of the mail item feed is set corresponding to the cost features input by the user.
Patent CA-2699845-C (CA)
Title: Methode et dispositif permettant de transporter de multiples articles
Inventor: BERGER GISBERT
IPC: B07C3/00
Filed: 2008-09-17
Granted: 2016-02-09
Abstract: L'invention concerne un procédé et un dispositif de transport de plusieurs objets, notamment d'envois postaux. Au moins un processus de transport est réalisé d'un stock intermédiaire (Af) vers un point de poursuite. Un signal de début (Start) est produit. Chaque objet ayant été transporté dans le stock intermédiaire (Af) avant production du signal de début (Start), est prélevé du stock intermédiaire (Af). Les objets (R0, S1) transportés au cours de ce processus de transport sont amenés du stock intermédiaire (Af) vers l'élément de transport (Beh-1) employé pour ce processus de transport. Après amenée des objets (R0, S1) dans l'élément de transport (Beh-1), un signal de fin est produit. Les objets (R0, S1, R1) ayant été transportés dans le stock intermédiaire (Af) entre la production du signal de début (Start) et la production du signal de fin (Q1) sont enregistrés. Le processus de transport est réalisé. Les objets (R0, S1) transportés dans l'élément de transport (Beh-1) sont prélevés de l'élément de transport (Beh-1). Pour chaque objet (R0, S1) transporté au cours de ce processus de transport, un ensemble de données est déterminé, celui-ci étant enregistré pour l'objet (R0, S1) concerné. L'ensemble de données enregistré est déterminé exclusivement au moyen d'ensembles de données produits pour les objets (R0, S1) correspondants, transportés dans le stock intermédiaire (Af) entre la production du signal de début (Start) et la production du signal de fin (Q1).
Patent CA-2703709-C (CA)
Inventor: BELL KENNETH F
IPC: F21W107/30
Filed: 2010-05-13
Granted: 2014-05-06
Abstract: A combined smoke detector and lighting unit includes a smoke detector sensor mounted to a housing, a light source mounted to the housing, and an electrical interface mounted to the housing. The electrical interface is in electrical communication with the smoke detector and the light source.
Patent CA-2703754-C (CA)
Title: Compositions et procedes pour traiter une inflammation
Inventor: WATSON RICHARD L
IPC: A61P29/00
Filed: 2008-10-24
Granted: 2019-04-09
Abstract: L'invention concerne de fluides générés électrocinétiquement (par exemple, des fluides ou solutions électrocinétiques enrichis en gaz) et des compositions pharmaceutiques et des procédés d'utilisation dans le traitement d'une inflammation ou d'au moins un symptôme d'inflammation. Les fluides générés électrocinétiquement ou les compositions pharmaceutiques et procédés comprennent des fluides aqueux générés électrocinétiquement facultativement en combinaison avec d'autres agents thérapeutiques. Des aspects particuliers concernent la régulation ou la modulation de la transduction de signal intracellulaire associée à des réponses inflammatoires par modulation d'au moins un parmi des membranes cellulaires, le potentiel de membrane, des protéines de membrane telles que des récepteurs membranaires comprenant, sans s'y limiter, les récepteurs couplés à la protéine G (GPCR) et les jonctions intercellulaires (par exemple, une jonction serrée, des jonctions communicantes, des adhérines de zona et des desmosomes). D'autres modes de réalisation comprennent des voies d'administration particulières ou des formulations pour les fluides générés électrocinétiquement (par exemple, des fluides et solutions enrichis en gaz générés électrocinétiquement) et des compositions thérapeutiques.
Patent CA-2703975-C (CA)
Inventor: HOMMES RONALDUS W J
IPC: D06L4/40
Filed: 2008-10-23
Granted: 2018-01-09
Abstract: The present invention provides methods and compositions comprising at least one neutral metalloprotease enzyme that has improved stability in the presence of a metal chelator. In some embodiments, the neutral metalloprotease finds use in cleaning and other applications comprising citrate. In some particularly preferred embodiments, the present invention provides methods and compositions comprising variant neutral metalloprotease(s) engineered to resist citrate-induced autolysis.
Patent CA-2708387-C (CA)
Inventor: SIMEK JAMES
IPC: G01N27/83
Filed: 2010-06-25
Granted: 2018-08-07
Abstract: A pipeline inspection tool has an even number of pole magnets, each spiraled about the tool body so that a second end of each magnet is offset amount "a" relative to a first end. The rotation a applied to the magnets produces a magnetic field oblique to the longitudinal body axis. In another aspect, the tool includes two pole magnets oriented at an oblique angle relative to the longitudinal axis body. An array of sensor coil sets is located between opposing edges of the two magnets and oriented perpendicular to the axis. Each set includes a transmitter coil and two opposing pairs of receiver coils that are gated to receive reflections from the wall of a tubular member. Because the line of coils is rotated relative to the magnetic bias field, the receiver coils are in-line with, and have the same angular orientation as, the transmitter coil.
Patent CA-2712170-C (CA)
Inventor: SUZUKI KAZUMI
IPC: A61K31/404
Filed: 2009-01-16
Granted: 2014-04-22
Abstract: A pharmaceutical composition comprising a compound represented by the general formula (I): (see formula I) or a salt thereof, and a pharmaceutically acceptable carrier, wherein the composition does not substantially contain a reducing sugar and/or a carrier containing a reducing sugar as an ingredient as the pharmaceutically acceptable carrier, or when the composition contains a reducing sugar and/or a carrier containing a reducing sugar as an ingredient as the pharmaceutically acceptable carrier, contact of the reducing sugar and the compound represented by the general formula (I) or a salt thereof is eliminated.
Patent CA-2713948-C (CA)
Inventor: VAAL RANDY J
IPC: E21B49/00
Filed: 2009-01-20
Granted: 2016-02-16
Abstract: An example method of integrating field data that includes obtaining the field data associated with a field and performing a produc-tion analysis on the field data to generate a production output, the produc-tion analysis performed by a production engineering tool. The method fur-ther includes transforming the field data to obtain transformed field data requested by a field application and sending the transformed field data from the production engineering tool to the field application, the field ap-plication performing a field analysis using the transformed field data to generate a field output. The method further includes generating a compari-son of the production output and the field output.
Patent CA-2716664-C (CA)
Title: Oxadiazoanthracene compounds
Inventor: MJALLI ADNAN M M
IPC: A61K31/5383
Filed: 2009-03-06
Granted: 2016-10-11
Abstract: The present invention provides oxadiazoanthracene derivatives of the formula (I) wherein A, B, C, R, R1, R2, R3, R4 and R5 are as herein described, pharmaceutical compositions comprising oxadiazoanthracene derivatives, and intermediates useful for the preparation of oxadiazoanthracene derivatives of Formula (I). (see formula I)
Patent CA-2719961-C (CA)
Inventor: BASAGLIA GIANNI
IPC: A61M1/36
Filed: 2009-04-02
Granted: 2015-06-30
Abstract: A medical apparatus comprises a machine (2) for treatment of fluids provided with means (3) for treating a patient-'s blood which exhibits a control unit (4) for sending command signals and receiving information relating to the treatment under way on the patient. The machine further comprises an internet web server (11) containing a predetermined number of web pages which are remotely accessible and consultable via a common web browser (18).  At least a web page reproduces the graphic user interface on the display (6) of the medical machine (2) substantially in real-time. A plurality of further information and data relat-ing to the medical machine is further published in the web pages.
Patent CA-2720408-C (CA)
Title: Use of pegylated igf-i variants for the treatment of neuromuscular disorders
Inventor: HOLTMANN BETTINA
IPC: A61K47/48
Filed: 2009-03-24
Granted: 2016-09-06
Abstract: The present invention relates to the pharmaceutical use of polyethylene glycol-(PEG)ylated IGF-I variants for the treatment, prevention and/or delay of progression of neuromuscular disorders, in particular amyotrophic lateral sclerosis (ALS).  More specifically, the present invention relates to the use of a PEGylated IGF-I variant for the manufacture of a pharmaceutical composition for the treatment, prevention and/or delay of neuromuscular disorders, in particular ALS wherein the PEGylated IGF-I variant is characterized in that it is derived from the wild- type human IGF-I amino acid sequence (SEQ ID NO: 1) and carries one or two amino acid alterations at amino acid positions 27, 65 and 68 so that one or two of amino acids at positions 27, 65 and 68 is/are a polar amino acid but not lysine and PEG is attached to at least one lysine residue.
Patent CA-2721776-C (CA)
Inventor: BREEDEN WINSTON
IPC: A47F5/08
Filed: 2010-11-18
Granted: 2014-07-15
Abstract: Un présentoir de marchandisage pour produits lourds et encombrants comprend un rail qui est soutenu par la paroi et les bras du présentoir fixés au rail. Les bras sont espacés des autres bras pour créer des colonnes et des rangées de stock de produits de détail. Le présentoir de marchandisage comprend également une structure offrant un index qui aide un consommateur à repérer facilement et aisément les produits de détail recherchés et d'autres produits complémentaires. Le stock supplémentaire accessible au consommateur se trouve derrière le premier produit de détail.